Neuberger Berman Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $196M | Buy |
349,707
+74,910
| +27% | +$48M | 0.15% | 149 |
|
|
2025
Q4 | $186M | Buy |
274,797
+653
| +0.2% | +$445K | 0.14% | 160 |
|
|
2025
Q3 | $175M | Sell |
274,144
-76,843
| -22% | -$46.6M | 0.13% | 193 |
|
|
2025
Q2 | $188M | Sell |
350,987
-64,154
| -15% | -$30.7M | 0.14% | 167 |
|
|
2025
Q1 | $174M | Buy |
415,141
+19,366
| +5% | +$8.41M | 0.15% | 173 |
|
|
2024
Q4 | $164M | Sell |
395,775
-21,699
| -5% | -$9.52M | 0.13% | 192 |
|
|
2024
Q3 | $211M | Sell |
417,474
-46,473
| -10% | -$22.6M | 0.16% | 158 |
|
|
2024
Q2 | $226M | Sell |
463,947
-8,415
| -2% | -$4.22M | 0.19% | 135 |
|
|
2024
Q1 | $255M | Sell |
472,362
-11,626
| -2% | -$6.35M | 0.21% | 125 |
|
|
2023
Q4 | $269M | Sell |
483,988
-3,858
| -0.8% | -$1.81M | 0.23% | 108 |
|
|
2023
Q3 | $213M | Sell |
487,846
-7,221
| -1% | -$3.6M | 0.19% | 140 |
|
|
2023
Q2 | $249M | Sell |
495,067
-3,444
| -0.7% | -$1.65M | 0.22% | 118 |
|
|
2023
Q1 | $249M | Sell |
498,511
-204,962
| -29% | -$98.1M | 0.23% | 119 |
|
|
2022
Q4 | $287M | Sell |
703,473
-12,829
| -2% | -$4.98M | 0.28% | 92 |
|
|
2022
Q3 | $233M | Sell |
716,302
-2,225
| -0.3% | -$817K | 0.24% | 102 |
|
|
2022
Q2 | $252M | Sell |
718,527
-12,795
| -2% | -$5.22M | 0.25% | 98 |
|
|
2022
Q1 | $400M | Sell |
731,322
-12,441
| -2% | -$6.54M | 0.34% | 60 |
|
|
2021
Q4 | $488M | Sell |
743,763
-16,390
| -2% | -$10.3M | 0.38% | 50 |
|
|
2021
Q3 | $471M | Sell |
760,153
-103,036
| -12% | -$69.2M | 0.41% | 44 |
|
|
2021
Q2 | $544M | Buy |
863,189
+94,286
| +12% | +$52.1M | 0.47% | 28 |
|
|
2021
Q1 | $376M | Sell |
768,903
-185,851
| -19% | -$93.1M | 0.36% | 44 |
|
|
2020
Q4 | $477M | Sell |
954,754
-142,529
| -13% | -$63.8M | 0.49% | 29 |
|
|
2020
Q3 | $431M | Sell |
1,097,283
-34,999
| -3% | -$12.9M | 0.51% | 27 |
|
|
2020
Q2 | $374M | Sell |
1,132,282
-43,795
| -4% | -$12.7M | 0.46% | 36 |
|
|
2020
Q1 | $285M | Sell |
1,176,077
-53,755
| -4% | -$14M | 0.43% | 44 |
|
|
2019
Q4 | $321M | Sell |
1,229,832
-31,896
| -3% | -$8.41M | 0.37% | 53 |
|
|
2019
Q3 | $343M | Sell |
1,261,728
-154,060
| -11% | -$42.9M | 0.42% | 45 |
|
|
2019
Q2 | $390M | Sell |
1,415,788
-84,755
| -6% | -$20.9M | 0.47% | 38 |
|
|
2019
Q1 | $336M | Sell |
1,500,543
-11,175
| -0.7% | -$2.31M | 0.41% | 47 |
|
|
2018
Q4 | $281M | Sell |
1,511,718
-53,457
| -3% | -$11M | 0.39% | 49 |
|
|
2018
Q3 | $391M | Sell |
1,565,175
-3,265
| -0.2% | -$793K | 0.44% | 41 |
|
|
2018
Q2 | $342M | Sell |
1,568,440
-46,633
| -3% | -$9.61M | 0.38% | 53 |
|
|
2018
Q1 | $309M | Sell |
1,615,073
-35,797
| -2% | -$6.61M | 0.35% | 60 |
|
|
2017
Q4 | $258M | Sell |
1,650,870
-70,718
| -4% | -$11.1M | 0.3% | 75 |
|
|
2017
Q3 | $268M | Sell |
1,721,588
-60,778
| -3% | -$9.61M | 0.33% | 63 |
|
|
2017
Q2 | $288M | Sell |
1,782,366
-201,318
| -10% | -$32.7M | 0.37% | 54 |
|
|
2017
Q1 | $307M | Sell |
1,983,684
-290,883
| -13% | -$40.1M | 0.4% | 49 |
|
|
2016
Q4 | $267M | Sell |
2,274,567
-236,026
| -9% | -$26.9M | 0.36% | 57 |
|
|
2016
Q3 | $283M | Sell |
2,510,593
-153,086
| -6% | -$16.1M | 0.38% | 53 |
|
|
2016
Q2 | $247M | Sell |
2,663,679
-50,094
| -2% | -$4.3M | 0.34% | 69 |
|
|
2016
Q1 | $213M | Sell |
2,713,773
-177,211
| -6% | -$12.8M | 0.29% | 93 |
|
|
2015
Q4 | $211M | Sell |
2,890,984
-262,971
| -8% | -$18.8M | 0.28% | 100 |
|
|
2015
Q3 | $234M | Sell |
3,153,955
-173,446
| -5% | -$12.4M | 0.3% | 91 |
|
|
2015
Q2 | $213M | Sell |
3,327,401
-315,053
| -9% | -$21.8M | 0.24% | 115 |
|
|
2015
Q1 | $281M | Sell |
3,642,454
-274,496
| -7% | -$21.4M | 0.3% | 88 |
|
|
2014
Q4 | $290M | Buy |
3,916,950
+293,230
| +8% | +$20.6M | 0.3% | 87 |
|
|
2014
Q3 | $213M | Sell |
3,623,720
-299,590
| -8% | -$18.9M | 0.22% | 131 |
|
|
2014
Q2 | $262M | Sell |
3,923,310
-139,664
| -3% | -$8.88M | 0.26% | 101 |
|
|
2014
Q1 | $247M | Sell |
4,062,974
-316,574
| -7% | -$18.9M | 0.25% | 110 |
|
|
2013
Q4 | $233M | Sell |
4,379,548
-214,274
| -5% | -$11.3M | 0.24% | 115 |
|
|
2013
Q3 | $229M | Sell |
4,593,822
-340,440
| -7% | -$16.4M | 0.25% | 109 |
|
|
2013
Q2 | $221M | Buy |
+4,934,262
| New | +$216M | 0.26% | 101 |
|
Other funds holding IDXX
VCM
VPM
Neuberger Berman Group's IDXX Position: Q1 2026 in Review
Neuberger Berman Group increased its Idexx Laboratories (IDXX) stake by 27% in Q1 2026, buying an estimated $48M and bringing the position to 349,707 shares worth $196M. The position accounts for 0.15% of the portfolio, ranked #149.
Neuberger Berman Group first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $544M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Neuberger Berman Group held 349,707 shares of Idexx Laboratories worth $196M as of Q1 2026.
- Neuberger Berman Group bought 74,910 Idexx Laboratories shares in Q1 2026, an estimated $48M.
- Idexx Laboratories made up 0.15% of Neuberger Berman Group's portfolio in Q1 2026, its #149 holding.
- Neuberger Berman Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's Idexx Laboratories position peaked at $544M in Q2 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.